STAGES AND METHODS OF DIAGNOSIS OF BRONCHOGENIC CARCINOMA IN HIWA CANCER HOSPITAL IN SULAIMANI CITY

Authors

  • Yad Noori M. Othman Hiwa Cancer Hospital, Sulaimani Health Directorate, Kurdistan Region, Iraq.
  • Kosar Mohamed Ali College of Medicine, University of Sulaimani, Kurdistan Region, Iraq.

DOI:

https://doi.org/10.17656/jsmc.10303

Keywords:

Bronchogenic carcinoma, Bronchoscopy, Non-small cell lung cancer, Small cell lung cancer

Abstract

Background 

Lung cancer is usually suspected in individuals who have an abnormal chest radiograph finding or have symptoms caused by either local or systemic effects of the tumour. The method and stage of diagnosis of suspected lung cancer depend on the type of lung cancer (i.e., small cell lung cancer [SCLC] or non-SCLC [NSCLC]), the size and location of the primary tumour, the presence of metastasis, and the overall clinical status of the patient.

Objectives 

To determine the stage and method of diagnosis of bronchogenic carcinoma in Hiwa cancer hospital.

Patients and Methods

A cross-sectional study, at which three hundred patients with lung cancer in Hiwa cancer hospital from 1st Jan. 2016 to 1st Feb. 2018 were evaluated, and as much as possible as data were collected and analyzed for stage, method, and histological type.

Results

The mean age for lung cancer was 65.7±10.7 years. Male: female ratio was 3.4:1. Smoking was present in (88%) of cases. Most of our cases (61.7%) were diagnosed by bronchoscopy, and most of them were non-small cell lung cancer was stage III & IV. There was a significant relationship between the method of diagnosis and stages of lung cancer (P-value=0.016). 

Conclusion

Most of our cases were males between 60–69-year-old, and smokers, without a family history, they presented with cough and were diagnosed by bronchoscopy (wash & biopsy) with metastatic disease, and their histological type was Non-small cell.

References

Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC Cancer Base No. 11. International Agency for research on cancer; Lyon, France: 2013. Available from: http:/globocan.iarc.fr.

American Cancer Society. Detailed guide: Lung cancer (non-small cell), What are the key statistics about lung cancer? Updated 2014 Aug 22. Available from: http://www.cancer org Cancer/Lung Cancer-Non-Small Cell Detailed Guide/non-small cell-lung-cancer-key-statistics.

Salim E, Jazieh A, Moore M. Lung cancer incidence in the Arab League Countries: risk factors and control. Asian Pac J Cancer Prev. 2011:12:17-34

Iraqi cancer board. Result of Iraqi cancer registry 2009. Baghdad, Iraqi cancer registry center: Ministry of Health, 2012.

Ettinger SD, Wood DE, Akerley W, Bazhenova LA, CamidgeDR.Chang AC, et al. NCCN guideline Cancer Network.2017. Available from: http://www.nccn.org professional’s physician gls/f guidelines.asp#site

American Joint Committee on Cancer (AJCC) Cancer Staging Manual. (8th edition) P.431-454.

Evidence-Based Clinical Practice Guidelines Initial Diagnosis of Lung Cancer: (2nd Edition) ACCP. 131S.

European Journal of cancer, Volume 45, Issue 8, May 2009, Pages 1389-1396 DOI: https://doi.org/10.1016/j.ejca.2008.11.043

Chest volume143, Issue 5, supplement, May 2013, Pages e211S-e250S. DOI: https://doi.org/10.1378/chest.12-2355

IARC Monographs on the evaluation of carcinogenic risk to humans. Tobacco smoke and Involuntary Smoking. Lyon, France: Interactional Agency for Research on Cancer,2004.

Devesa S, Bray F, A. Vizcaino AP. Parkin DM. International lung cancer trends by histologic type: male: female differences diminishing and adenocarcinoma rates rising. Int. J. Cancer. 2005 Mar 3; 117:294-299. DOI: https://doi.org/10.1002/ijc.21183

Basmy AE, Shihab A, Ahmed A. Profile of lung cancer in Kuwait. Asian Pac J Cancer Prev. 2013;14 (10):6181-6184 DOI: https://doi.org/10.7314/APJCP.2013.14.10.6181

Hosseini M, Naghan AP, Karimi S. ScyedAlinaghi S, Bahadori M, Khodadad K, et al. Environmental risk factors for lung cancer in Iran: a case-control study. Int J Epidemiol. 2009:38:989-996. DOI: https://doi.org/10.1093/ije/dyp218

Alberg AJ, Nonemaker J. Who is at high risk for lung cancer? Population-level and individual-level perspectives. Semin Respir Crit Care Med. 2008:29(3):223-32. DOI: https://doi.org/10.1055/s-2008-1076742

Alwan A. Health in Iraq. Ministry of Health, 2nd. ed. Baghdad, 2004.

Ferguson MK, Skosey C, Hoffman PC, Golomb HM. Sex associated differences in presentation and survival in patients with lung cancer. J Clin Oncol 1990:8:1402-1407. DOI: https://doi.org/10.1200/JCO.1990.8.8.1402

Al-Rahim YA. Lung cancer in a sample of Iraqi patients. Al-Kindy Col Med J. 2007:4 (1):53-59. Hajmanoochehri F, Mohammadi N, Zohal, Sodagar A, Ebiehaj

Bethesda MD. SEER cancer statistics factsheets: Lung and bronchus cancer. NCI. Available from: http://seer.cancer.gov/statfacts/html/lungb.htm

Cancer research UK. Lung cancer incidence statistics, cancer stats. London. 2014 available from: http: www.cancerresearchuk.org info/cancer stats/types/ ung'incidence'uk-lung-cancer-incidence-statistics.

Spiro SG. Gould MK, Colice Gl; American College of Chest Physicians. Initial evaluation of the patient with lung cancer: Symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP Evidenced-Based Clinical Practice Guidelines (2ndEdition). Chest. 2007; 132:149S-60s. DOI: https://doi.org/10.1378/chest.07-1358

EhsanUllah, Reyaz N, Aziz F. Nagi AH, Ashraf M. Demographic and clinicopathological parameters in lung cancer in a chest hospital, Lahore - Pakistan. Biomedica. 2012:28:14-17

Ooi WL, Elston RC, Chen VW, Bailey-Wilson JE, Rothschild H. Increased familial risk for lung cancer. J Natl Cancer Inst. 1986; 76:217-22

Shaw GL, Falk RT, Pickle LW, Mason TT, Bufler PA. Lung cancer risk associated with cancer in relatives. J Clin Epidemiol. 1991 44: 429-37. DOI: https://doi.org/10.1016/0895-4356(91)90082-K

Matakidou A, Eisen T, Houlston RS. A systematic review of the relationship between family history and lung cancer risk. Br J Cancer. 2005:93:825 33 DOI: https://doi.org/10.1038/sj.bjc.6602769

Parkin DM, Bray F, Ferlay J. Global cancer statistics, 2002. CA Cancer J Clin 2005:55(2):74-108. DOI: https://doi.org/10.3322/canjclin.55.2.74

Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers-a different disease. Nat Rev Cancer. 2007;7(10):778-790. DOI: https://doi.org/10.1038/nrc2190

Wakelee HA, Chang ET, Gomez SL, Gomez SL, Keegan TH, Feskanich D, et al. Lung cancer incidence in never smokers. J Clin Oncol. 2007:25(5):472 478. DOI: https://doi.org/10.1200/JCO.2006.07.2983

Hirayama T. Non-smoking wives of heavy smokers have a higher risk of lung cancer a study from Japan. Br Med J (Clin Res Ed). 1981:282(6259):183-185. DOI: https://doi.org/10.1136/bmj.282.6259.183

Hackshaw AK, Law MR, Wald NJ. The accumulated evidence on lung cancer and environmental tobacco smoke. BMJ. 1997:315(71 14):980-98:8 DOI: https://doi.org/10.1136/bmj.315.7114.980

Radzikowska E, Glaz P, Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. A population-based study of 20 561 cases. Ann Oncol. 2002:13(7):1087-1093. DOI: https://doi.org/10.1093/annonc/mdf187

Published

2021-06-21

How to Cite

1.
Othman Y, Ali K. STAGES AND METHODS OF DIAGNOSIS OF BRONCHOGENIC CARCINOMA IN HIWA CANCER HOSPITAL IN SULAIMANI CITY. JSMC [Internet]. 2021 Jun. 21 [cited 2024 Jun. 24];11(2):195-203. Available from: https://jsmc.univsul.edu.iq/index.php/jsmc/article/view/jsmc-10303

Similar Articles

1-10 of 86

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)